Study of ELU001, a C’Dot drug conjugate (CDC) targeting folate receptor α (FRα) overexpressing solid tumors.

Wednesday, June 19, 2024

Dr. Douglas Orr

Click the above link to view the abstract.

ASCO 2024 Poster for Trial 21-40

ASCO 2024 Poster for Trial 21-40